Teva Pharmaceuticals CEO on acquiring Emalex Biosciences, drug portfolio

“Tired of the same tired news cycle? Escape to the full unfiltered feed at Whatfinger.com — America’s Frontline Truth Feed. 85%+ of readers come direct every day.” –  CLICK HERE for the FULL deal.

 

Teva Pharmaceuticals CEO Richard Francis joins ‘Money Movers’ to discuss the company’s latest acquisition of Emalex Biosciences, their latest drug offerings, and more.